arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Solventum Corp

SOLV
$87.11 ▼ -2.16 (-2.41%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
16 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Bullish
auto_awesome

Analytical Summary

Solventum Corp shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $15.0B
Dividend Yield —
Revenue Growth 2.2% ↗
Op. Margin 8.2% ↗
ROIC 1.7% ↗
FCF / Share $0.83 ↗
Trailing P/E 164.4x
Price / Book 3.1x
FCF Yield 1.0%
Debt / Equity 0.95
info Valuation on last close. End-of-day price, Nov 5, 2026.

16-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.21B
↑ +2.2% —
Net Income Profit after all expenses
$92.00M
↑ +2.2% —
Operating Margin Operating profit as % of sales
8.2%
↑ +103.0% 83th
FCF / Share Free cash flow per share
$0.83
↑ +153.2% —
Long-Term Debt Long-term obligations
$4.57B
— 0.0% —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
62
Returns ↑
93
Financial Health ↑
51
Cash Quality
22

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 5 years · 16 quarters